María Natalia Gandur Quiroga: Highlights from the article ‘Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals’
María Natalia Gandur Quiroga posted on LinkedIn about recent paper by Irma Bisceglia et al., titled “Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals” published on Frontiers.
Authors: Irma Bisceglia, Maria Laura Canale, Nicola Silvestris, Giuseppina Gallucci, Andrea Camerini, Alessandro Inno, Massimiliano Camilli, Fabio Maria Turazza, Giulia Russo, Andrea Paccone, Raffaella Mistrulli, Leonardo De Luca, Stefania Angela Di Fusco, Luigi Tarantini, Fabiana Lucà, Stefano Oliva, Antonella Moreo, Nicola Maurea, Vincenzo Quagliariello, Giuseppina Rosaria Ricciardi, Chiara Lestuzzi, Damiana Fiscella, Iris Parrini, Vito Racanelli, Antonio Russo, Lorena Incorvaia, Fabio Calabrò, Giuseppe Curigliano, Saverio Cinieri, Michele Massimo Gulizia, Domenico Gabrielli, Fabrizio Oliva, Furio Colivicchi
“Highlights from the article ‘Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals’: published on Frontiers
This paper is a must-read for healthcare professionals!
- Cancer survivorship requires a multidisciplinary, patient-centered approach.
- Collaboration between oncologists and cardiologists is crucial for continuous, personalized care.
- Emphasizes a preventive model in cardio-oncology to manage cardiovascular risks.
- Implementation of specific care plans for cancer survivors, considering familial, social, and environmental factors.
- Non-pharmacological and pharmacological strategies to reduce cardiovascular risk.”
Source: María Natalia Gandur Quiroga/LinkedIn
Maria Natalia Gandur Quiroga is a Medical Oncologist and Chief of the Division of Genitourinary Medical Oncology at the Ángel H. Roffo Oncology Institute in Buenos Aires, Argentina. She is a Professor of Medicine at the University of Buenos Aires at the Oncologists Post Graduates Studies. Her research focuses on clinical trials with aims to improve the treatment of patients with urologic tumors. She is an active member of the European Association for Cancer Research, Argentinian Medical Association and American Society of Clinical Oncology.